Ablation Verses Anti-arrhythmic Therapy for Reducing All Hospital Episodes From Recurrent Atrial Fibrillation

NACompletedINTERVENTIONAL
Enrollment

321

Participants

Timeline

Start Date

May 1, 2015

Primary Completion Date

September 30, 2018

Study Completion Date

November 27, 2018

Conditions
Heart FailureRecurrent Atrial Fibrillation
Interventions
PROCEDURE

AVATAR-AF ablation

Experimental ablation protocol

DRUG

Anti-Arrhythmic therapy

"Group 2 will be prescribed medication listed below:~Amiodarone; Dronaderone; Sotalol Beta blockers; Calcium channel blockers; Flecainide; or Propafenone.~You will then be discharged from clinic. A research nurse will contact you by phone to make sure there are no problems and can make hospital appointments if needed."

PROCEDURE

Conventional AF ablation

Conventional ablation procedure

Trial Locations (13)

BH4 7DW

The Royal Bournemouth Hospital, Bournemouth

BN2 1ES

Brighton University Hospital, Brighton

CV2 1EP

Coventry University Hospital, Coventry

Unknown

Eastbourne District General Hospital, Eastbourne

New Cross Hospital, Wolverhampton

HU16 5JQ

Castle Hill Hospital, Hull

LS1 3EX

Leeds General Infirmary, Leeds

L14 3PE

Liverpool Heart and Chest Hospital, Liverpool

EC1A 7BE

St Bartholomew's Hospital, London

W12 0NN

Hammersmith Hospital, London

NE7 7DN

Freeman Hospital, Newcastle

PO6 3LY

Queen Alexandra Hospital, Portsmouth

S5 7AU

Sheffield University Hospital, Sheffield

All Listed Sponsors
lead

Imperial College London

OTHER

NCT02459574 - Ablation Verses Anti-arrhythmic Therapy for Reducing All Hospital Episodes From Recurrent Atrial Fibrillation | Biotech Hunter | Biotech Hunter